NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Categories: Newsweek


Newsweek trumpets an ‘aggressive’ new cancer drug, but where’s the data?


Newsweek overlooks key limitation of study on vitamin D and childhood obesity


Newsweek story on Zika vaccine to zap brain cancer is fascinating–but needed more caution about mouse research


Newsweek’s premature optimism about experimental ovarian cancer drug overlooks costs, harms and limitations of the evidence


Newsweek prematurely reports ‘promise’ for ketamine as a treatment for depressed teens


Newsweek’s story on the 16:8 diet: It’s not much more than a news release rewrite, but it’s at least cautious


Here’s one detail that should be included in almost all stories about cancer screening studies


Newsweek stokes false hope with ‘cure for baldness’ based on preliminary evidence


Like so many news stories before it, Newsweek article makes male birth control pill sound imminent


Retinal scans to detect heart attack risk? Newsweek offers a blurry picture